Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks

Gerald D. Weinstein, John Y.M. Koo, Gerald G. Krueger, Mark G. Lebwohl, Nicholas J. Lowe, M. Alan Menter, Deborah A. Lew-Kaya, John Sefton, John R. Gibson, Patricia S. Walker, Ernest Ast, Jerry Bagel, Debra L. Breneman, Ross D. Bright, Steven A. Davis, Madeleine Duvic, Drore Eisen, Steven R. Feldman, Virginia C. Fiedler, Richard FitzpatrickDavid P. Fivenson, Bernard S. Goffe, Jon M. Hanifin, Steven R. Hong, Terry M. Jones, Steven E. Kempers, Stephen J. Kraus, Paul A. Krusinski, James J. Leyden, J. Michael Maloney, Bruce H. Miller, David M. Pariser, Tania J. Phillips, Blas Reyes, Owen Reynolds, Toivo E. Rist, Glenn G. Russo, Joel S. Shavin, Daniel Stewart, Leonard J. Swinyer, Eduardo H. Tschen, David I. Wolf

Research output: Contribution to journalArticlepeer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks'. Together they form a unique fingerprint.

Medicine & Life Sciences